NeuroscienceBrainPeer-reviewed
ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration
Katheryn A Q Cousins, David John Irwin, David A. Wolk…·Jeffrey S. Phillips
This paper evaluates the ATN framework's accuracy in diagnosing Alzheimer's disease subtypes and frontotemporal lobar degeneration using cerebrospinal fluid biomarkers, finding that non-amnestic Alzheimer's patients have lower tau levels and the framework is less sensitive to frontotemporal lobar degeneration.
37 citations